Radioiodine Thyroid Remnant Ablation after Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal in Patients with High-Risk Differentiated Thyroid Cancer
Table 2
Ablation characteristics by patient group.
Variable
rhTSH group (n = 18)
THW group (n = 27)
P
Cumulative radioiodine activity before ablation success evaluation, GBq (mCi), mean ± SD